Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-22-025209

Chief Financial Officer sold 4,000 shares at $212.02 ($848,068)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Sandercock Brett Chief Financial Officer 2022-11-07 Sale −4,000 $212.02 $848,068 106,303 D
Open-market sales · 4,000 sh · avg $212.02 · $848,068
Loading xslF345X03/form4.xml…